4//SEC Filing
Kunkle Lisa K. 4
Accession 0001127602-21-029442
CIK 0001122976other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:30 PM ET
Size
27.0 KB
Accession
0001127602-21-029442
Insider Transaction Report
Form 4
AVIENT CORPAVNT
Kunkle Lisa K.
SVP Gnrl Counsel & Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-11-15$35.07/sh+7,100$248,997→ 81,126 total - Exercise/Conversion
Common Stock
2021-11-15$38.27/sh+8,500$325,295→ 84,150 total - Exercise/Conversion
Common Stock
2021-11-15$24.98/sh+11,500$287,270→ 88,841 total - Disposition to Issuer
Common Stock
2021-11-15$59.58/sh−7,784$463,771→ 81,057 total - Disposition to Issuer
Common Stock
2021-11-15$59.58/sh−5,476$326,260→ 75,650 total - Exercise/Conversion
Stock Appreciation Rights
2021-11-15−8,500→ 0 totalExercise: $38.27Exp: 2025-02-04→ Common Stock (8,500 underlying) - Exercise/Conversion
Common Stock
2021-11-15$23.08/sh+10,400$240,032→ 80,010 total - Disposition to Issuer
Common Stock
2021-11-15$59.58/sh−6,809$405,680→ 77,341 total - Disposition to Issuer
Common Stock
2021-11-15$59.58/sh−5,984$356,527→ 74,026 total - Exercise/Conversion
Stock Appreciation Rights
2021-11-15−7,100→ 0 totalExercise: $35.07Exp: 2024-02-11→ Common Stock (7,100 underlying) - Exercise/Conversion
Stock Appreciation Rights
2021-11-15−11,500→ 0 totalExercise: $24.98Exp: 2026-02-10→ Common Stock (11,500 underlying) - Sale
Common Stock
2021-11-16$60.22/sh−11,447$689,381→ 69,610 total - Exercise/Conversion
Stock Appreciation Rights
2021-11-15−10,400→ 0 totalExercise: $23.08Exp: 2023-02-15→ Common Stock (10,400 underlying)
Holdings
- 1,986.271(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The sale price is a weighted average for the sale transactions. The sales prices range from a low of $59.44 per share to a high of $60.84. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, Avient Corporation or a security holder of Avient Corporation.
- [F2]The information in this report is based on a Avient Retirement Savings Plan statement as of November 15, 2021.
- [F3]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $23.08 per share and no more than one-third of the grant can vest per year during the first three years.
- [F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.
- [F5]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
- [F6]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.
Documents
Issuer
AVIENT CORP
CIK 0001122976
Entity typeother
Related Parties
1- filerCIK 0001632842
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:30 PM ET
- Size
- 27.0 KB